6F9

7-(3,5-dimethoxyphenyl)-N-[(3S)-1-methylpiperidin-3-yl]-4-propanoyl-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide

Created:	2016-03-29
Last modified:	2016-10-05

Find Related PDB Entry
1 entries where 6F9 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	70
Chiral Atom Count	1
Bond Count	73
Aromatic Bond Count	12

2D diagram of 6F9

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	7-(3,5-dimethoxyphenyl)-N-[(3S)-1-methylpiperidin-3-yl]-4-propanoyl-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide
Systematic Name (OpenEye OEToolkits)	7-(3,5-dimethoxyphenyl)-~{N}-[(3~{S})-1-methylpiperidin-3-yl]-4-propanoyl-3,5-dihydro-2~{H}-1,4-benzoxazepine-9-carboxamide
Formula	C₂₇ H₃₅ N₃ O₅
Molecular Weight	481.584
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O(c4cc(cc(c1cc3c(c(c1)C(NC2CN(C)CCC2)=O)OCCN(C3)C(=O)CC)c4)OC)C
SMILES	CACTVS	3.385	CCC(=O)N1CCOc2c(C1)cc(cc2C(=O)N[CH]3CCCN(C)C3)c4cc(OC)cc(OC)c4
SMILES	OpenEye OEToolkits	2.0.4	CCC(=O)N1CCOc2c(cc(cc2C(=O)NC3CCCN(C3)C)c4cc(cc(c4)OC)OC)C1
Canonical SMILES	CACTVS	3.385	CCC(=O)N1CCOc2c(C1)cc(cc2C(=O)N[C@H]3CCCN(C)C3)c4cc(OC)cc(OC)c4
Canonical SMILES	OpenEye OEToolkits	2.0.4	CCC(=O)N1CCOc2c(cc(cc2C(=O)N[C@H]3CCCN(C3)C)c4cc(cc(c4)OC)OC)C1
InChI	InChI	1.03	InChI=1S/C27H35N3O5/c1-5-25(31)30-9-10-35-26-20(16-30)11-18(19-12-22(33-3)15-23(13-19)34-4)14-24(26)27(32)28-21-7-6-8-29(2)17-21/h11-15,21H,5-10,16-17H2,1-4H3,(H,28,32)/t21-/m0/s1
InChIKey	InChI	1.03	CUJLWYCUPPPASA-NRFANRHFSA-N

Related Resource References

Resource Name	Reference
PubChem	122172830
ChEMBL	CHEMBL3927642

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.